SGCTG

NiCCC

A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium

Trial Number
NCT02866370 (ClinicalTrials.gov Identifier)
Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
Subscribe to SGCTG